BRPI0719826A8 - Composição sólida termoestável, e, processo de preparar uma composição farmacêutica sólida - Google Patents

Composição sólida termoestável, e, processo de preparar uma composição farmacêutica sólida

Info

Publication number
BRPI0719826A8
BRPI0719826A8 BRPI0719826A BRPI0719826A BRPI0719826A8 BR PI0719826 A8 BRPI0719826 A8 BR PI0719826A8 BR PI0719826 A BRPI0719826 A BR PI0719826A BR PI0719826 A BRPI0719826 A BR PI0719826A BR PI0719826 A8 BRPI0719826 A8 BR PI0719826A8
Authority
BR
Brazil
Prior art keywords
preparing
solid
composition
thermastable
micelles
Prior art date
Application number
BRPI0719826A
Other languages
English (en)
Inventor
P Möschwitzer Jan
Original Assignee
Solvay Pharm Bv
Abbott Healthcare Products Bv
Abbvie Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Bv, Abbott Healthcare Products Bv, Abbvie Bv filed Critical Solvay Pharm Bv
Priority claimed from PCT/EP2007/061194 external-priority patent/WO2008046905A1/en
Publication of BRPI0719826A2 publication Critical patent/BRPI0719826A2/pt
Publication of BRPI0719826A8 publication Critical patent/BRPI0719826A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

COMPOSIÇÃO SÓLIDA TERMOESTÁVEL, E, PROCESSO DE PREPARAR UMA COMPOSIÇÃO FARMACÊUTICA SÓLIDA A presente invenção diz respeito a uma composição sólida termoestável contendo micelas nanodimensionadas, as micelas contendo uma substância química fracamente solúvel, tal como uma substância biologicamente ativa, dissolvida em um material auxiliar, e as micelas sendo implantadas em um carreador solúvel em água. A invenção ainda diz respeito a um processo para preparar uma composição sólida termoestável e a um processo para preparar as formas de dosagem farmacêuticas compreendendo a mesma.
BRPI0719826A 2006-10-20 2007-10-19 Composição sólida termoestável, e, processo de preparar uma composição farmacêutica sólida BRPI0719826A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06122648 2006-10-20
PCT/EP2007/061194 WO2008046905A1 (en) 2006-10-20 2007-10-19 Micellar nanoparticles of chemical substances

Publications (2)

Publication Number Publication Date
BRPI0719826A2 BRPI0719826A2 (pt) 2014-05-06
BRPI0719826A8 true BRPI0719826A8 (pt) 2017-04-04

Family

ID=37671256

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0719826A BRPI0719826A8 (pt) 2006-10-20 2007-10-19 Composição sólida termoestável, e, processo de preparar uma composição farmacêutica sólida

Country Status (8)

Country Link
CN (2) CN104188926A (pt)
AR (1) AR063330A1 (pt)
BR (1) BRPI0719826A8 (pt)
HK (1) HK1199829A1 (pt)
MX (1) MX2009004124A (pt)
SA (1) SA07280548B1 (pt)
TW (1) TWI392507B (pt)
UA (1) UA97496C2 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI661841B (zh) * 2017-04-19 2019-06-11 三凡生技研發股份有限公司 用於分散疏水性植物萃取物之載劑
EP3424493A1 (en) * 2017-07-07 2019-01-09 SolMic Research GmbH Stable cannabinoid compositions
CN110302155B (zh) * 2019-07-31 2021-09-21 江南大学 一种黄原胶共聚物纳米胶束的制备方法及其应用
CN112915121A (zh) * 2019-12-06 2021-06-08 汉义生物科技（北京）有限公司 一种大麻素纳米胶束制剂及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9700866B2 (en) * 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
CN1268321C (zh) * 2001-07-13 2006-08-09 那野伽利阿株式会社 内部包有药物的高分子胶束的冻结干燥用组合物和该胶束的制备方法
IL153277A0 (en) * 2002-12-04 2003-07-06 Pharmos Corp High enantiomeric purity dexanabinol for pharmaceutical compositions
US20060003976A1 (en) * 2004-06-04 2006-01-05 Yuehua Zhang Cholesterol/bile acid/bile acid derivative-modified therapeutic drug compounds

Also Published As

Publication number Publication date
TW200824711A (en) 2008-06-16
TWI392507B (zh) 2013-04-11
BRPI0719826A2 (pt) 2014-05-06
SA07280548B1 (ar) 2011-10-08
CN104188926A (zh) 2014-12-10
AR063330A1 (es) 2009-01-21
HK1199829A1 (en) 2015-07-24
UA97496C2 (ru) 2012-02-27
MX2009004124A (es) 2009-07-22
CN101686946A (zh) 2010-03-31

Similar Documents

Publication Publication Date Title
UY29562A1 (es) Compuestos heterocíclicos de amino benzoilo, composiciones farmacéuticas que los contienen, procedimientos de preparación y aplicaciones
UY30759A1 (es) Compuestos quimicos
BRPI0508540B8 (pt) composto, composição farmacêutica, e, uso de um composto
EA201071218A1 (ru) Улучшенные композиции для активных фармацевтических компонентов с плохой проницаемостью
BRPI0508579A (pt) composto, composição farmacêutica, e, uso de um composto
WO2010047765A8 (en) Nanostructures for drug delivery
AR052184A1 (es) Mezclas fungicidas
CR11641A (es) Derivados heterociclicos de urea y metodos de uso de los mismos-211
GT200500155A (es) Terapia del càncer resistente al platino
GT200900056A (es) Benzoxazoles y oxazolopiridinas utiles como inhibidores de la quinasa janus
WO2009109927A3 (en) Glp-1 receptor agonists and related active pharmaceutical ingredients for treatment of cancer
UY29767A1 (es) Derivados de benzotiazolonas, procesos para su preparación, composiciones farmacéuticas que los contienen y aplicaciones
BRPI0512986A (pt) novos derivados de hidantoìna
WO2007075825A3 (en) Lipophilic anticancer drug compounds
UY29370A1 (es) Derivados de tiazol, composiciones que lo contienen, procedimientos de preparación y aplicaciones
UY28366A1 (es) Compuestos químicos
CR11259A (es) Bromhidrato de bupropion y aplicaciones terapueticas
UY30544A1 (es) Compuestos de pirrolo-piperidina y sales farmacéuticametne aceptables de los mismos, procesos de fabricacion, composiciones y aplicaciones
AR072685A1 (es) Composicion topica para el tratamiento de queratosis actinica
ECSP11011558A (es) Nuevos compuestos químicos.
DOP2010000374A (es) Derivados heterociclicos de la urea y sus metodos de empleo
UA86441C2 (ru) (2-гидроксиэтил)триметиламмония тиоктат (холина тиоктат), имеющий гепатопротекторное, гипоаммониемическое и детоксицирующее действие, способ его получения, фармацевтическая композиция на его основе
CY1118461T1 (el) Φαρμακευτικες συνθεσεις που περιλαμβανουν αναστολεα αρωματασης
WO2012168885A9 (en) Bisacodyl and its analogues as drugs for use in the treatment of cancer
BRPI0719826A8 (pt) Composição sólida termoestável, e, processo de preparar uma composição farmacêutica sólida

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: ABBOTT HEALTHCARE PRODUCTS B.V. (NL)

B25A Requested transfer of rights approved

Owner name: ABBVIE B.V (NL)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 13A ANUIDADE.

B07F Notification of approval that there is no relation to art. 229 of lpi (pipeline patents) [chapter 7.6 patent gazette]
B11R Patent application dismissed according to article 229 of the patent law [chapter 11.18 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2599 DE 27-10-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.